Oxford Nanopore Technologies Ltd Asset Resilience Ratio
Oxford Nanopore Technologies Ltd asset resilience ratio. Oxford Nanopore Technologies Ltd (ONT) has an Asset Resilience Ratio of 7.45% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ONT days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Oxford Nanopore Technologies Ltd (2012–2025)
Asset resilience ratio of Oxford Nanopore Technologies Ltd from 2012 to 2025. This chart shows how Oxford Nanopore Technologies Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Oxford Nanopore Technologies Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Oxford Nanopore Technologies Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Oxford Nanopore Technologies Ltd balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX42.10 Million | 7.45% |
| Total Liquid Assets | GBX42.10 Million | 7.45% |
Asset Resilience Insights
- Limited Liquidity: Oxford Nanopore Technologies Ltd maintains only 7.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Oxford Nanopore Technologies Ltd Industry Peers by Asset Resilience Ratio
Compare Oxford Nanopore Technologies Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Samsung Biologics Co Ltd
KO:207940 |
Biotechnology | 15.21% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
Biotechnology | 5.07% |
|
Immunovant Inc
NASDAQ:IMVT |
Biotechnology | 98.50% |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
Biotechnology | 21.11% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Amicus Therapeutics Inc
NASDAQ:FOLD |
Biotechnology | 8.37% |
Oxford Nanopore Technologies Ltd Asset Resilience Ratio by Year (2012–2025)
Oxford Nanopore Technologies Ltd asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Oxford Nanopore Technologies Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 11.92% | GBX74.20 Million ≈ $9.03K |
GBX622.50 Million ≈ $75.74K |
-6.79pp |
| 2024-12-31 | 18.71% | GBX138.85 Million ≈ $16.89K |
GBX742.05 Million ≈ $90.29K |
+12.34pp |
| 2023-12-31 | 6.37% | GBX49.51 Million ≈ $6.02K |
GBX777.06 Million ≈ $94.55K |
-8.12pp |
| 2022-12-31 | 14.49% | GBX119.41 Million ≈ $14.53K |
GBX823.89 Million ≈ $100.24K |
-1.02pp |
| 2021-12-31 | 15.52% | GBX130.63 Million ≈ $15.89K |
GBX841.87 Million ≈ $102.43K |
-17.59pp |
| 2018-12-31 | 33.11% | GBX58.00 Million ≈ $7.06K |
GBX175.19 Million ≈ $21.32K |
+24.73pp |
| 2017-12-31 | 8.38% | GBX10.00 Million ≈ $1.22K |
GBX119.31 Million ≈ $14.52K |
-29.37pp |
| 2016-12-31 | 37.75% | GBX60.00 Million ≈ $7.30K |
GBX158.94 Million ≈ $19.34K |
-3.67pp |
| 2015-12-31 | 41.42% | GBX45.06 Million ≈ $5.48K |
GBX108.77 Million ≈ $13.23K |
-9.96pp |
| 2014-12-31 | 51.38% | GBX36.12 Million ≈ $4.39K |
GBX70.30 Million ≈ $8.55K |
+3.24pp |
| 2013-12-31 | 48.14% | GBX33.15 Million ≈ $4.03K |
GBX68.87 Million ≈ $8.38K |
+3.77pp |
| 2012-12-31 | 44.37% | GBX23.05 Million ≈ $2.80K |
GBX51.95 Million ≈ $6.32K |
-- |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more